So as with most with well with many pharmaceuticals certainly, there is a secondary effect of certain types of medication and in this case there was identified, you know, considerable weight loss in diabetics using GLP-1 receptor agonists
Less common: Mild nausea, headache, or temporary fatigue
China, Canada, Japan, and European countries are Novo Nordisks largest markets after the United States, the company wrote in a 2024 business filing to the US Securities and Exchange Commission (SEC)
Binding activates Gq/11 signaling, raises intracellular IP3 and diacylglycerol, triggers calcium release from the endoplasmic reticulum, and drives GH vesicle exocytosis
doi:10.1056/NEJMoa2413258 Younossi ZM, Mangla KK, Chandramouli AS, et al
This innovative approach enables patients to achieve weight loss with medical assistance, avoiding the necessity for invasive procedures or aggressive stimulants